|
15-05-2024
|
|
|
|
| Aurobindo Pharma Limited has informed the Exchange about Loss of Share Certificates |
|
|
|
|
|
15-05-2024
|
|
|
|
| AUROBINDO PHARMA LIMITED has informed the Exchange about Loss of share certificates |
|
|
|
|
|
10-05-2024
|
|
|
|
| Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of US FDA Inspection at Unit VII of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company'. |
|
|
|
|
|
07-05-2024
|
|
|
|
| Aurobindo Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. |
|
|
|
|
|
06-05-2024
|
|
|
|
| Aurobindo Pharma Limited has informed the Exchange about receipt of NCL Order approving the Scheme of Amalgamation |
|
|
|
|
|
03-05-2024
|
|
|
|
| Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of US FDA Inspection at Unit II of Eugia Pharma Specialities Ltd. a wholly owned subsidiary of the Company'. |
|
|
|
|
|
03-05-2024
|
|
|
|
| Aurobindo Pharma Limited has informed the Exchange regarding 'With reference to the above, we are submitting all the required details as per SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 with regard to an order received from the Deputy Commissioner, Punjagutta (ST) STU-1 of GST, Punjagutta Division, Hyderabad under the provisions of the Central Goods and Services Tax Act, 2017 and TGST Act 2017 for the FY 2018-19 demanding reversal of ITC and payment of GST amounting to Rs. 6,54,50,645 along with interest of Rs.5,92,20,900 and also levying a penalty of Rs. 65,51,354/-, the disclosure of which was submitted on May 2, 2024.'. |
|
|
|
|
|
02-05-2024
|
|
|
|
| Aurobindo Pharma Limited has informed the Exchange about Acquisition |
|
|
|
|
|
02-05-2024
|
|
|
|
| Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of Disposal of business assets of Eugia US Manufacturing LLC, a wholly owned step- down subsidiary of the Company'. |
|
|
|
|
|
02-05-2024
|
|
|
|
| Aurobindo Pharma Limited has informed the Exchange regarding 'The Company has received an order from the Deputy Commissioner, Punjagutta (ST) STU-1 of GST, Punjagutta Division, Hyderabad passed under relevant provisions of the Central Goods and Services T |
|
|
|
|
|